• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马尔尼菲青霉感染致特发性非肝硬化性门静脉高压症 1 例报告。

Idiopathic non-cirrhotic portal hypertension in a patient with Talaromyces marneffei infection: a case report.

机构信息

Department of Gastroenterology, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, People's Republic of China.

出版信息

BMC Infect Dis. 2023 Mar 1;23(1):125. doi: 10.1186/s12879-023-08090-6.

DOI:10.1186/s12879-023-08090-6
PMID:36859274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9979503/
Abstract

BACKGROUND

The etiopathogenesis of idiopathic non-cirrhotic portal hypertension (INCPH) is so far poorly understood. Altered immunity, blood diseases, infections, congenital defects and drug exposure have been documented in a part of patients with INCPH owing to increased recognition of the disorder in patients with HIV, or various haematological disorders or autoimmune diseases. We aim to discuss the possible etiopathogenesis of INCPH.

CASE PRESENTATION

We reported that a patient with intestinal infection of T. Marneffei and hyper-IgE syndrome, a group of rare primary immunodeficiency disorders, was finally diagnosed with INCPH for gastroesophageal variceal bleeding. The diagnosis was mainly based on histopathological features. Transjugular intrahepatic portosystemic shunt was performed and there was no recurrence of melena during the six-month follow-up.

CONCLUSION

In the context of immunodeficiency, INCPH may associated with intestinal infections. Thus, screening for enterogenic infection and immunological disorders in patients with unexplained portal hypertension is necessary.

摘要

背景

特发性非肝硬化性门静脉高压症(INCPH)的病因学至今仍知之甚少。由于人们对 HIV 患者、各种血液系统疾病或自身免疫性疾病患者中这种疾病的认识增加,部分 INCPH 患者的免疫改变、血液疾病、感染、先天性缺陷和药物暴露已被记录下来。我们旨在讨论 INCPH 的可能病因学。

病例介绍

我们报告了一例患有马尔尼菲青霉肠道感染和高免疫球蛋白 E 综合征的患者,这是一组罕见的原发性免疫缺陷疾病,最终因胃食管静脉曲张出血而被诊断为 INCPH。该诊断主要基于组织病理学特征。进行了经颈静脉肝内门体分流术,在六个月的随访期间没有再次出现黑便。

结论

在免疫缺陷的情况下,INCPH 可能与肠道感染有关。因此,对于不明原因的门静脉高压症患者,有必要筛查肠源性感染和免疫性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/af0118bf23c5/12879_2023_8090_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/bc78a121110e/12879_2023_8090_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/b2048727d868/12879_2023_8090_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/6212fc414464/12879_2023_8090_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/af0118bf23c5/12879_2023_8090_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/bc78a121110e/12879_2023_8090_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/b2048727d868/12879_2023_8090_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/6212fc414464/12879_2023_8090_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e73e/9979503/af0118bf23c5/12879_2023_8090_Fig4_HTML.jpg

相似文献

1
Idiopathic non-cirrhotic portal hypertension in a patient with Talaromyces marneffei infection: a case report.马尔尼菲青霉感染致特发性非肝硬化性门静脉高压症 1 例报告。
BMC Infect Dis. 2023 Mar 1;23(1):125. doi: 10.1186/s12879-023-08090-6.
2
TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis.经颈静脉肝内门体分流术治疗特发性非肝硬化性门静脉高压症患者的静脉曲张出血:与肝硬化患者的比较。
Aliment Pharmacol Ther. 2019 Apr;49(7):926-939. doi: 10.1111/apt.15186. Epub 2019 Feb 28.
3
A POEMS syndrome patient with idiopathic non-cirrhotic portal hypertension received the transjugular intrahepatic portosystemic shunt: a case report and literature review.POEMS 综合征伴特发性非肝硬化性门静脉高压患者行经颈静脉肝内门体分流术:病例报告及文献复习。
Niger J Clin Pract. 2022 Nov;25(11):1939-1944. doi: 10.4103/njcp.njcp_360_22.
4
Non-cirrhotic portal hypertension - diagnosis and management.非肝硬化性门静脉高压症——诊断与管理。
J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23.
5
[Non-cirrhotic portal hypertension - The point of view of the pathologis].非肝硬化性门静脉高压症——病理学家的观点
Ther Umsch. 2019;76(7):359-363. doi: 10.1024/0040-5930/a001106.
6
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.非肝硬化门静脉高压患者的自然史:与代偿性肝硬化患者的比较。
Dig Liver Dis. 2018 Aug;50(8):839-844. doi: 10.1016/j.dld.2018.01.132. Epub 2018 Jan 31.
7
Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.HIV 相关性特发性非肝硬化性门静脉高压的危险因素和预后。
Aliment Pharmacol Ther. 2012 Nov;36(9):875-85. doi: 10.1111/apt.12049.
8
Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.肝硬化患者门静脉高压性静脉曲张出血的手术门体分流术与经颈静脉肝内门体分流术对比研究
Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD001023. doi: 10.1002/14651858.CD001023.pub3.
9
[Clinical efficacy of transjugular intrahepatic portosystemic shunt for gastrointestinal hemorrhage in patients with idiopathic noncirrhotic portal hypertension].经颈静脉肝内门体分流术治疗特发性非肝硬化门静脉高压症患者胃肠道出血的临床疗效
Zhonghua Nei Ke Za Zhi. 2022 May 1;61(5):548-551. doi: 10.3760/cma.j.cn112138-20210902-00608.
10
Transjugular intrahepatic portosystemic shunt and splenectomy are more effective than endoscopic therapy for recurrent variceal bleeding in patients with idiopathic noncirrhotic portal hypertension.经颈静脉肝内门体分流术和脾切除术在治疗特发性非肝硬化门静脉高压症患者复发性静脉曲张出血方面比内镜治疗更有效。
World J Clin Cases. 2020 May 26;8(10):1871-1877. doi: 10.12998/wjcc.v8.i10.1871.

本文引用的文献

1
Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.肺 talaromycosis:一种洞察地方性真菌病免疫发病机制的窗口。
Mycopathologia. 2021 Oct;186(5):707-715. doi: 10.1007/s11046-021-00570-0. Epub 2021 Jul 6.
2
Talaromyces marneffei infection in non-HIV-infected patients in mainland China.中国大陆地区非 HIV 感染者中马尔尼菲篮状菌感染。
Mycoses. 2021 Oct;64(10):1170-1176. doi: 10.1111/myc.13295. Epub 2021 Jun 27.
3
Porto-sinusoidal vascular disease: proposal and description of a novel entity.窦周隙血管病:一种新实体的提出与描述。
Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0.
4
Hyper IgE syndromes: clinical and molecular characteristics.高免疫球蛋白 E 综合征:临床和分子特征。
Immunol Cell Biol. 2019 Apr;97(4):368-379. doi: 10.1111/imcb.12209. Epub 2018 Nov 19.
5
Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition.特发性非肝硬化性门静脉高压相关门静脉血管改变的组织学:命名和定义。
Histopathology. 2019 Jan;74(2):219-226. doi: 10.1111/his.13738. Epub 2018 Oct 17.
6
Idiopathic Portal Hypertension.特发性门静脉高压症。
Hepatology. 2018 Dec;68(6):2413-2423. doi: 10.1002/hep.30132.
7
DOCK8 deficiency: Insights into pathophysiology, clinical features and management.DOCK8缺陷:对病理生理学、临床特征及管理的见解。
Clin Immunol. 2017 Aug;181:75-82. doi: 10.1016/j.clim.2017.06.003. Epub 2017 Jun 15.
8
Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.经颈静脉肝内门体分流术在特发性非肝硬化性门静脉高压症严重并发症管理中的作用。
Hepatology. 2016 Jul;64(1):224-31. doi: 10.1002/hep.28547. Epub 2016 May 13.
9
Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.非HIV感染患者的马尔尼菲篮状菌(青霉菌)感染
Emerg Microbes Infect. 2016 Mar 9;5(3):e19. doi: 10.1038/emi.2016.18.
10
Comprehensive Screening of Gene Function and Networks by DNA Microarray Analysis in Japanese Patients with Idiopathic Portal Hypertension.日本特发性门静脉高压症患者基因功能和网络的DNA微阵列分析综合筛查
Mediators Inflamm. 2015;2015:349215. doi: 10.1155/2015/349215. Epub 2015 Oct 4.